The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer

G. M. Yousef, A. Scorilas, A. Magklara, N. Memari, R. Ponzone, P. Sismondi, N. Biglia, M. Abd Ellatif, E. P. Diamandis

Research output: Contribution to journalArticlepeer-review

Abstract

Many kallikrein genes were found to be differentially expressed in various malignancies, and prostate specific antigen (encoded by the KLK3 gene) is the best tumour marker for prostate cancer. Prostate specific antigen has recently been shown to be an independent favourable prognostic marker for breast cancer. KLK15 is newly discovered kallikrein gene that is located adjacent to KLK3 on chromosome 19q13.4. KLK15 has 41% similarity to KLK3 and the encoded protein, hK15, can activate proprostate specific antigen. We studied the expression of KLK15 by real-time quantitative reverse transcriptase - polymerase chain reaction in 202 tissues from patients with breast carcinoma of various stages, grades and histological types. KLK15 expression was found to be a significant predictor of progression-free survival (hazard ratio of 0.41 and P=0.011) and overall survival (hazard fatio of 0.34 and P=0.009). When all other known confounders were controlled in the multivariate analysis, KLK15 retained its prognostic significance. Higher concentrations of KLK15 mRNA were found more frequently in node negative patients (P=0.042). No association was found between KLK15 expression and any other clinicopathological variable. Further, KLK15 is an independent prognostic factor of progression-free survival and overall survival in the subgroup of patients with lower grade and those with oestrogen receptor and progesterone receptor negative tumours in both univariate and multivariate analysis. KLK15 levels of expression were slightly higher (although not statistically significant) in the oestrogen receptor negative and progesterone receptor negative subgroups of patients. KLK15 is up-regulated by androgens in breast cancer cell lines. Time-course and blocking experiments suggest that this regulation is mediated through the androgen receptor.

Original languageEnglish
Pages (from-to)1294-1300
Number of pages7
JournalBritish Journal of Cancer
Volume87
Issue number11
DOIs
Publication statusPublished - Nov 18 2002

Keywords

  • Breast cancer
  • Cancer genes
  • Kallikreins
  • KLK15
  • Predictive markers
  • Prognostic factors
  • Serine proteases
  • Steroid hormones
  • Tumour markers

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint

Dive into the research topics of 'The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer'. Together they form a unique fingerprint.

Cite this